Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial ; volume:15 ; number:1 ; day:10 ; month:9 ; year:2015 ; pages:1-8 ; date:12.2015
BMC pediatrics ; 15, Heft 1 (10.9.2015), 1-8, 12.2015
- Urheber
-
Khanal, Aayush
- Beteiligte Personen und Organisationen
-
Sharma, Arun
Basnet, Srijana
Sharma, Pushpa Raj
Gami, Fakir Chandra
SpringerLink (Online service)
- DOI
-
10.1186/s12887-015-0434-4
- URN
-
urn:nbn:de:1111-2016110919467
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khanal, Aayush
- Sharma, Arun
- Basnet, Srijana
- Sharma, Pushpa Raj
- Gami, Fakir Chandra
- SpringerLink (Online service)
Ähnliche Objekte (12)
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial)
Comparison of hypertonic saline versus normal saline on cytokine profile during CABG
A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
No Benefit of 3% Hypertonic Saline Following Experimental Intracerebral Hemorrhage
Bronchiolitis
Hypertonic saline induces inflammation in human macrophages through the NLRP1 inflammasome
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial)
Comparison of hypertonic saline versus normal saline on cytokine profile during CABG
A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
No Benefit of 3% Hypertonic Saline Following Experimental Intracerebral Hemorrhage
Bronchiolitis
Hypertonic saline induces inflammation in human macrophages through the NLRP1 inflammasome
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial)
Comparison of hypertonic saline versus normal saline on cytokine profile during CABG
A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
No Benefit of 3% Hypertonic Saline Following Experimental Intracerebral Hemorrhage
Bronchiolitis
Hypertonic saline induces inflammation in human macrophages through the NLRP1 inflammasome
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis